Clinical Trials Browser

Ureteral Neoplasms × copanlisib × Genitourinary × Clear all

NCT05687721 2025-06-15

Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer

Phase 1/2 Withdrawn

Urinary Bladder Neoplasms, Ureteral Neoplasms